IRCT201506203930N38已完成2 期
Effects of Memantine to improve cognitive disorders caused by ECT in patients with major depressive disorder
Shiraz University of Medical Sciences, Vice Chancellor for Research0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Aged between 18 to 65, both gender, major depressive dsorder using DSM-IV criteria
- •Exclusion criteria: serious medical condition, hypothyroidism, bipolar mood disorder, pregnancy
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Memantine effect on patients with schizophreniaSchizophrenia.SchizophreniaIRCT20190606043827N1Kashan University of Medical Sciences50
招募中
3 期
Evaluation of the effect of Memantine in patients with brain tumorsCognitive Impairment.Mild cognitive impairment, so statedG31.84IRCT20211029052903N1Esfahan University of Medical Sciences70
已完成
2 期
Effectiveness of Memantine in improvement of cognitive deficits in specific learning disorderspecific learning disorder.Developmental disorder of scholastic skills, unspecifiedIRCT2015102124633N1Vice Chancellor for research of Arak University of Medical Sciences94
已完成
3 期
Study on Cognitive Disorders of Multiple SclerosisMultiple SclerosisNCT01074619University Hospital, Caen90
已完成
3 期
Effect of Memantine on epileptic patientsEpilepsy.Epilepsy and recurrent seizuresIRCT20121110011424N5Tehran University of Medical Sciences60